Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| PIRTOBRUTINIB | Jaypirca | 100 | 41745.00 | Details | |
| LENALIDOMIDE | Lammalid | 5 | 11206.25 | Details | |
| LENALIDOMIDE | Lammalid | 10 | 11749.75 | Details | |
| LENALIDOMIDE | Lammalid | 15 | 11749.75 | Details | |
| LENALIDOMIDE | Lammalid | 25 | 13611.50 | Details | |
| TRIFLURIDINE,TIPIRACIL | Trumavar | 20,8.19 | 2343.70 | Details | |
| CICLOSPORIN | VERKAZIA | 1 | 1324.95 | Details | |
| AMIKACIN | ARIKAYCE | 590 | 53873.70 | Details | |
| HUMAN C1-ESTERASE INHIBITOR | Haegarda | 2000 | 10499.80 | Details | |
| HUMAN C1-ESTERASE INHIBITOR | Haegarda | 3000 | 15749.70 | Details | |
| RIVAROXABAN | Rivaroxaban MCP | 10 | 64.15 | Details | |
| RIVAROXABAN | Rivaroxaban MCP | 15 | 167.70 | Details | |
| Bevacizumab | KRABEVA 400 mg per 16 ml | 25 | 2666.35 | Details | |
| ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN) | Idelvion | 250 | 2323.55 | Details | |
| ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN) | Idelvion | 500 | 4647.10 | Details | |
| ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN) | Idelvion | 1000 | 9294.30 | Details | |
| ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN) | Idelvion | 2000 | 18588.60 | Details | |
| ALBUTREPENONACOG ALFA (RECOMBINANT FUSION PROTEIN LINKING COAGULATION FACTOR IX WITH ALBUMIN) | Idelvion | 3500 | 35978.05 | Details | |
| PALONOSETRON HYDROCHLORIDE | Etalon 0.25 mg per 5 ml | 0.05 | 139.00 | Details | |
| PROPOFOL | Propofol - Lipuro 1000 mg per 50 ml | 20 | 629.60 | Details |
6.82% of users said yes from 132 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.